iShares Global Healthcare ETF
BlackRock (iShares) · Since 2009
Annual fee
0.41%
$41/yr per $10,000
Fund size
$1.3B
AUD
Dividend yield
1.65%
Quarterly · approx. as at Q2 2026
Holdings
N/A
data not available
Next estimated distribution: ~June 2026 (estimated, not guaranteed; confirm with the fund manager). Distribution calendar →
IXJ provides exposure to global healthcare companies across pharmaceuticals, medical devices, biotechnology and healthcare services. The fund holds a diversified portfolio of international healthcare equities, offering thematic investment in the healthcare sector. With a MER of 0.41% per year, it tracks a broad global healthcare index. General information only, not financial advice.
Based on publicly available fund data. General information only, not a recommendation to buy or sell.
Strengths
Watch out for
Holdings, sector and geography breakdowns for this fund are approximate, based on fund category and index. Actual composition may differ. General information only.
| Company | Weight |
|---|---|
| UnitedHealth Group Inc. | 5.8% |
| Eli Lilly and Company | 5.2% |
| Johnson and Johnson | 4.6% |
| AbbVie Inc. | 4.1% |
| Merck & Co., Inc. | 3.8% |
| Thermo Fisher Scientific Inc. | 3.2% |
| Abbott Laboratories | 2.9% |
| Danaher Corporation | 2.6% |
| Medtronic PLC | 2.3% |
| Becton Dickinson and Company | 2.1% |
See how IXJ combines with your other ETFs: Stock X-Ray →
| Sector | Weight |
|---|---|
| Health Care | 88% |
| Other | 12% |
| Country | Weight |
|---|---|
| United States | 55% |
| Other | 45% |
You know what IXJ owns. Do you know what your whole portfolio owns?
The Portfolio Builder combines all your ETFs into one view, real overlap, real sector exposure, real fee cost in dollars.
Portfolio Builder is Pro · $19/month · Cancel anytime
Compare IXJ with similar ETFs
Side-by-side fees, holdings overlap and performance. General information only.
Find near-twins of IXJ →General information only, not financial advice. ETFLens does not hold an AFSL. Always read the relevant PDS and consider seeking advice from a licensed financial adviser.
IXJ provides exposure to global healthcare companies across pharmaceuticals, medical devices, biotechnology and healthcare services. General information only, not financial advice.
IXJ's annual management fee is 0.41% per year ($41 per $10,000 invested). General information only, not financial advice.
IXJ pays distributions quarterly. Distributions are not guaranteed and will vary. General information only, not financial advice.